Top 20 Companies in Microbiome Manufacturing Market 2025: Strategic Overview and Future Trends (2024–2035)
RELEASE DATE: Sep 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Microbiome Manufacturing Market Size is projected to Grow from USD 26.2 Billion in 2024 to USD 146.5 Billion by 2035, at a CAGR of 16.94% during the forecast period 2025–2035. The market for Microbiome Manufacturing is growing demand due to the increasing development in the microbiome sector and expanding GMP-compliant manufacturing capabilities.
Introduction
The Microbiom Manufacturing Market Size is an industry involving the development and production of products that are derived from the beneficial microorganisms for health and agriculture. The increasing requirement of effective therapy, drugs and cancer remedies is increasing the growth of microbiom construction. Furthermore, with the increasing demand for novel microbiom therapeutics, increase the technological progress that streamlines the manufacturing process. Probiotics and advanced microbiom-based medical science growth contributed to promoting microbiom manufacturing market with increasing demand for personal healthcare.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights-Download the Brochure now and dive deeper into the future of the Microbiome Manufacturing Market.
Microbiome Manufacturing Market Size & Statistics
- The Market Size for Microbiome Manufacturing Was estimated to be worth USD 26.2 Billion in 2024.
- The Market Size is going to Expand at a CAGR of 16.94% between 2025 and 2035.
- The Global Microbiome Manufacturing Market Size is anticipated to reach USD 146.5 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Microbiome Manufacturing Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Microbiome Manufacturing Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Microbiome Manufacturing market.
It is fueled by advances in sequencing technology and bioinformatics tools. Further, the development of innovative microbiome-based products, from probiotics to fecal microbiota transplantation therapies, is anticipated to propel market demand.
North America is expected to generate the highest demand during the forecast period in the Microbiome Manufacturing market.
It is driven by the presence of biotech companies pioneering live microbial therapeutics. An increasing collaboration with contract manufacturing organizations that offer technical expertise across different scales of operations is propelling the market growth.
Top 10 Trends in the Microbiome Manufacturing Market
- Integration of AI and Digitalization
- Strategic Partnerships and Collaborations
- Personalized Medicine and Live Biotherapeutics
- Advancements in Sequencing Technologies
- Growing Demand for Consumer-Friendly Products
- Focus on GMP Manufacturing and Standardization
- Application of Quality by Design (QbD) Principles
- Expansion into Diagnostics and Therapeutics
- Increased Investment and Funding
- Addressing Regulatory Complexities
1. Integration of AI and Digitalization
The adoption of Artificial Intelligence (AI), Internet of Things (IoT), and big data analytics is transforming microbiome research, diagnostics, and manufacturing processes, leading to more efficient and precise outcomes.
2. Strategic Partnerships and Collaborations
An increase in partnerships between microbiome companies, academia, and contract manufacturers is fostering innovation and accelerating the commercialization of new microbiome-based therapies and products.
3. Personalized Medicine and Live Biotherapeutics
The trend towards personalized approaches is driving the development and manufacturing of personalized microbiome-based therapies and live biotherapeutics, including fecal microbiota transplantation (FMT).
4. Advancements in Sequencing Technologies
Improved and more affordable next-generation sequencing technologies are lowering the cost of microbiome analysis, making it easier to develop and manufacture customized products.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Microbiome Manufacturing market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 10 Companies Leading the Microbiome Manufacturing Market
- Seres Therapeutics
- Vedanta Biosciences
- Finch Therapeutics
- Rebiotix (a Ferring company)
- MaaT Pharma
- Cerbios-Pharma
- WACKER
- Chr. Hansen
- UAS Labs
- Sun Genomics
- Others
1. Seres Therapeutics
Headquarters: U.S.
Seres Therapeutics holds a significant position in the microbiome manufacturing market as a developer of microbiome-based therapeutics, notably with the FDA-approved VOWST for recurrent C. difficile infection. They maintain manufacturing capabilities, leverage partnerships with companies like Nestlé Health Science for commercialization, and work with contract manufacturing organizations such as Bacthera to increase supply for their products like SER-109 and potentially others.
2. Vedanta Biosciences
Headquarters: U.S.
Vedanta Biosciences is a prominent player in the microbiome manufacturing market, focusing on the production of defined bacterial consortia for oral medicines, differentiating itself through its proprietary platform for discovery, design, and cGMP manufacturing of bacterial-based therapies. The company's approach bypasses the need for human donors, using pure bacterial strains from its extensive library to create consistent, scalable, and highly controlled drugs, positioning itself as a leader in developing a new class of microbiome-based therapeutics.
3. Finch Therapeutics
Headquarters: U.S.
Finch Therapeutics was a clinical-stage company developing microbiome-based drugs, but in early 2023, it discontinued its Phase 3 trial for recurrent C. difficile infection and shifted focus to realizing the value of its assets and intellectual property (IP) through potential partnerships and collaborations. The company developed both donor-derived and donor-independent microbiome therapeutics and held a large IP portfolio and a biorepository of strains and samples, but has since been delisted from Nasdaq and is working to manage its assets.
4. Ribiotix
Headquarters: USA
Rebiotix is a company focused on developing microbiome-based therapies, known for its Microbiota Restoration Therapy (MRT) platform used to treat diseases by delivering beneficial live microbes to the patient's gut. Acquired by Ferring Pharmaceuticals in 2018, Rebiotix is a key player in the microbiome manufacturing market because its technology requires specialized manufacturing processes for live, complex biological products, positioning it and Ferring at the forefront of this innovative therapeutic field.
Are you ready to discover more about the Microbiome Manufacturing market?
The report provides an in-depth analysis of the leading companies operating in the global Microbiome Manufacturing market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Seres Therapeutics
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Vedanta Biosciences
- Finch Therapeutics
- Rebiotix (a Ferring company)
- MaaT Pharma
- Cerbios-Pharma
- WACKER
- Chr. Hansen
- UAS Labs
- Sun Genomics
- Others
Conclusion
The Microbiome Manufacturing Market Size is a rapidly expanding industry driven by a growing demand for novel therapeutics and health products derived from beneficial microorganisms. Its growth is fueled by advancements in technology, particularly sequencing and bioinformatics, and is characterized by a strong trend toward personalized medicine and live biotherapeutics. Strategic partnerships, increased investment, and a focus on standardizing manufacturing processes are shaping the market landscape. While North America leads in overall demand due to its robust biotech sector and the presence of pioneering companies, the Asia Pacific region is experiencing the fastest growth, propelled by increasing R&D and a demand for personalized health solutions. The market is evolving with the integration of AI and digital tools, and leading companies are actively developing new therapies to address a wide range of health conditions.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?